FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Akorn Atropine Sulfate Ophthalmic Solution Recall

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL…

Akorn, Inc. · Gurnee, IL

Risk level
Class III
Reported by FDA
Feb 15, 2023
Recall ID
D-0265-2023
Check your lot numberHow we source this data

Summary

Akorn recalled Atropine Sulfate Ophthalmic Solution starting Jan 30, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0265-2023 on Feb 15, 2023. Reason: Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint. Status: Ongoing.

Why it was recalled

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Product description

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Lot numbers, UPCs & expiration codes

Lot: 081031A, Exp 2/28/2023

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0265-2023
Classification
Class III
Status
Ongoing
Recall initiated
Jan 30, 2023
FDA report date
Feb 15, 2023
Quantity
45,117 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0265-2023, exactly as published.

Show all FDA fields
City
Gurnee
State
IL
Status
Ongoing
Country
United States
Event ID
91580
Address
5605 Centerpoint Ct Ste A
Code information
Lot: 081031A, Exp 2/28/2023
Postal code
60031-5278
Report date
Feb 15, 2023
Product type
Drugs
Recall number
D-0265-2023
Classification
Class III
Recalling firm
Akorn, Inc.
Product quantity
45,117 Bottles
Reason for recall
Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jan 30, 2023
Initial firm notification
Letter
Center classification date
Feb 8, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0265-2023, published Feb 15, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls